Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Austin

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Plos One|July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysJonathan A Lee, Paul Shinn, Susan Jaken, et al.
Environmental Health Perspectives|July 31, 2018
Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic StudiesMenghang Xia, Ruili Huang, Qiang Shi, et al.
Current Topics in Medicinal Chemistry|November 29, 2013
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseElizabeth A Ottinger, Mark L Kao, Nuria Carrillo-Carrasco, et al.
Chemical Research in Toxicology|November 3, 2020
The Tox21 10K Compound Library: Collaborative Chemistry Advancing ToxicologyAnn M Richard, Ruili Huang, Suramya Waidyanatha, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
ACS Medicinal Chemistry Letters|February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of MalariaRichard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2002
A role for the melanocortin 4 receptor in sexual functionLex H T Van der Ploeg, William J Martin, Andrew D Howard, et al.
Nature Genetics|September 2, 2004
The knockout mouse projectChristopher P Austin, James F Battey, Allan Bradley, et al.
Clinical and Translational Science|June 8, 2018
Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug DiscoveryNathan P Coussens, G Sitta Sittampalam, Rajarshi Guha, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Plos One|July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysJonathan A Lee, Paul Shinn, Susan Jaken, et al.
Environmental Health Perspectives|July 31, 2018
Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic StudiesMenghang Xia, Ruili Huang, Qiang Shi, et al.
Current Topics in Medicinal Chemistry|November 29, 2013
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseElizabeth A Ottinger, Mark L Kao, Nuria Carrillo-Carrasco, et al.
Chemical Research in Toxicology|November 3, 2020
The Tox21 10K Compound Library: Collaborative Chemistry Advancing ToxicologyAnn M Richard, Ruili Huang, Suramya Waidyanatha, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
ACS Medicinal Chemistry Letters|February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of MalariaRichard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2002
A role for the melanocortin 4 receptor in sexual functionLex H T Van der Ploeg, William J Martin, Andrew D Howard, et al.
Nature Genetics|September 2, 2004
The knockout mouse projectChristopher P Austin, James F Battey, Allan Bradley, et al.
Clinical and Translational Science|June 8, 2018
Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug DiscoveryNathan P Coussens, G Sitta Sittampalam, Rajarshi Guha, et al.
Pageof 22